Max Robotics — Global Service Robot Directory + US Certification

About

Franco J. Vizeacoumar is a leading researcher in functional genomics and cancer biology, best known for pioneering high-throughput platforms that bridge the gap between molecular tools and therapeutic discovery. His major contributions include the development of an industrialized pipeline for generating recombinant antibodies to folded proteins—a breakthrough that produced validated antibodies for 346 transcription factors, addressing a critical need for renewable, permanent reagents in biology and medicine. This work, cited over 120 times, has enabled more reliable and scalable studies of protein function. Vizeacoumar’s research also focuses on synthetic lethality and genome-wide CRISPR screens, where he has identified novel vulnerabilities in cancer cells, advancing precision oncology. His notable achievements include leading large-scale collaborative projects that integrate functional genomics with drug target discovery, and his work has been widely recognized for its impact on both basic research and translational applications. With a citation count exceeding 5,000, Vizeacoumar continues to drive innovation in cancer therapeutics, making his profile essential for students and researchers interested in the intersection of technology, genetics, and disease treatment.